Cargando…
Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects
Disruption of the cell cycle is among the most effective approach to increase tumour cells’ radio-sensitivity. However, the presence of dose-limiting side effects hampers the clinical use of tyrosine kinase inhibitors targeting the cell cycle. Towards addressing this challenge, we identified a bosut...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028769/ https://www.ncbi.nlm.nih.gov/pubmed/36945003 http://dx.doi.org/10.1186/s12951-023-01848-9 |